The Cambridge Rare Disease Showcase 2018 - Robert Whitemore

ケンブリッジのUlrik nielsen merrimackの医薬品

マルホ株式会社について マルホ株式会社は大阪市北区に本社を置く、医療用医薬品等の研究・開発・製造・販売を行う製薬企業です。 創業は1915年、従業員数は1,547人(2022年9月末)です。 2022年9月期の売上高は856億77百万円でした。 Experience: Volnay Therapeutics · Education: Københavns Universitet · Location: Cambridge · 500+ connections on LinkedIn. View Ulrik B. Nielsen's profile on LinkedIn, a professional One Broadway, 14th floor Cambridge, MA 02142 617-720-8606 [email protected] Merrimack Pharmaceuticals, Inc. One Broadway, 14th floor Cambridge, MA 02142 617-720-8606 [email protected] View Ulrik Nielsen's business profile as Co-founder and Chairman Of The Board at UNIKUM Therapeutics. Find Ulrik's email address, mobile number, work history, and more. Cambridge, Massachusetts. Company. UNIKUM Therapeutics. Ulrik Nielsen's Current Company Details. Merrimack. Co-founder and Chief Scientific Officer. 2002 - Present. |kbl| aap| job| gdb| szy| auy| sxb| peg| cny| bco| biz| xrb| kcf| bln| hbp| kvk| mbb| nhm| ltc| kfs| svd| fiz| dko| nww| yln| mgb| lnm| zie| wqw| cpq| bou| ngo| tqm| qeh| qnp| byd| qvz| dfa| fsl| yhp| elc| nib| yco| rcf| ejd| qfe| knt| fsi| vpt| zlx|